How much does Ensidipine cost in India?
Enasidenib is an oral small molecule targeted drug used to treat specific types of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
Encidipine is not yet available in the country, so patients cannot purchase it domestically and need to purchase it through overseas channels. The cheaper ones abroad are generic drugs, especially the Laos version and the Bangladeshi version. The price ranges from more than 2,000 yuan to more than 4,000 yuan, and the ingredients of the original drugs and generic drugs are basically the same.

Currently, there are no officially marketed generic drugs of ensidipine in India, only generic drugs marketed in Laos and Bangladesh.
Ensidipine works by inhibiting the activity of IDH2 (isocitrate dehydrogenase 2) mutant, a mutation commonly found in MDS and AML patients. IDH2Mutation leads to abnormal accumulation of isocitrate, which in turn affects cell differentiation and proliferation and promotes the development of leukemia.
As a targeted drug, ensidipine is specific and can selectively inhibit the activity of mutatedIDH2enzyme, thereby interfering with abnormal metabolic pathways and inhibiting the proliferation of leukemia cells. This specific inhibition can reduce adverse effects on normal cells, and ensidipine is generally better tolerated than traditional chemotherapy drugs.
Clinical trials have shown that ensidipine has demonstrated significant therapeutic effects in some MDS and AML patients, including complete remission and durable clinical responses in some patients. However, treatment efficacy and tolerability may vary among all patients, so treatment regimens need to be tailored to the individual patient's circumstances.
Although ensidipine has shown potential efficacy in treating certain types of myelodysplastic syndromes and acute myeloid leukemia, it may still cause some adverse effects, such as nausea, vomiting, fatigue, etc. Therefore, when using ensidipine, it is necessary to closely monitor the patient's condition, take appropriate treatment measures in a timely manner, and adjust the treatment plan if necessary.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)